Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

NCT03051009 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

503

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: Desmopressin ODT 25 μg
DRUG: Desmopressin ODT 50 μg

Sponsor

Ferring Pharmaceuticals